Inventor
OBST SANDER ULRIKE
CH24 patents
⚠️ This page may combine multiple inventors who share the name “OBST SANDER ULRIKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
19 patentsUS12209091B2Jan 28, 2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
HOFFMANN LA ROCHE7 citations85
US7879845B2Feb 1, 2011
Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
HOFFMANN LA ROCHE7 citations83
US10723729B2Jul 28, 2020
BACE1 inhibitors
HOFFMANN LA ROCHE1 citations73
US10399969B2Sep 3, 2019
BACE1 inhibitors
HOFFMANN LA ROCHE2 citations73
US10047081B2Aug 14, 2018
BACE1 inhibitors
HOFFMANN LA ROCHE3 citations73
US10246468B2Apr 2, 2019
BACE1 inhibitors
HOFFMANN LA ROCHE3 citations72
US11034687B2Jun 15, 2021
BACE1 inhibitors
HOFFMANN LA ROCHE0 citations62
US9278918B2Mar 8, 2016
Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors
HOFFMANN LA ROCHE2 citations62
US7812028B2Oct 12, 2010
3-pyridinecarboxamide derivatives as HDL-cholesterol raising agents
HOFFMANN LA ROCHE5 citations59
US9809599B2Nov 7, 2017
Aryl-quinoline derivatives
HOFFMANN LA ROCHE0 citations52
US9604977B2Mar 28, 2017
Bicyclic thiophenylamide compounds
HOFFMANN LA ROCHE1 citations52
US9090565B2Jul 28, 2015
1-pyridazinyl-hydroxyimino-3-phenyl-propanes
HOFFMANN LA ROCHE1 citations52
US10829500B2Nov 10, 2020
Pyridyl-triazabicycles
HOFFMANN LA ROCHE0 citations51
US10696691B2Jun 30, 2020
BACE1 inhibitors
HOFFMANN LA ROCHE0 citations51
US9920072B2Mar 20, 2018
BACE1 inhibitors
HOFFMANN LA ROCHE1 citations51
US8030308B2Oct 4, 2011
Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors
HOFFMANN LA ROCHE0 citations51
US9562052B2Feb 7, 2017
Bicyclicpyridine derivatives
HOFFMANN LA ROCHE0 citations42
US9353102B2May 31, 2016
Non-annulated thiophenylamides
HOFFMANN LA ROCHE0 citations42
US9896438B2Feb 20, 2018
2,2,2-trifluoroethyl-thiadiazines
HOFFMANN LA ROCHE0 citations38